Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dronabinol Chewing Gum vs Marinol in Healthy Volunteers
NCT03098940Phase 1Unknown
- Sponsor
- AXIM Biotechnologies, Inc.
- Start
- Jan 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dronabinol in chemotherapy-induced nausea and vomiting (CINV) and anorexia nervosa (AN) (2 arms), sponsored by AXIM Biotechnologies, Inc. Primary endpoint: Bioequivalence at 48 hours. Status: unknown.
02
Drugs
dronabinol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT03098940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098940.